Herantis Pharma Plc.
Biotechnology Research in Finland
Overview
Herantis Pharma Plc is a clinical-stage biotechnology company developing disease-modifying therapies for Parkinson’s disease. The Company’s lead product, HER-096, is a first-in-class small peptide that combines the neuroprotective mechanism of cerebral dopamine neurotrophic factor (CDNF), with the convenience of subcutaneous administration. In a Phase 1b clinical trial, HER 096 was shown to be generally safe and well tolerated in Parkinson’s disease patients. Herantis plans to advance HER-096 into a Phase 2 clinical trial in 2027 to evaluate efficacy, safety and tolerability in early-stage Parkinson’s patients. Herantis is listed on the Nasdaq First North Growth Market Finland.
Tagline
Herantis Pharma Plc is a clinical-stage biotechnology company developing disease modifying therapies for Parkinson’s.
EMPLOYEES
11-50 employees
FOUNDED
2008
HQ
Espoo, Southern Finland
TYPE
Public Company
Location
- Street
- Bertel Jungin aukio 1
- City
- Espoo
- Region
- Southern Finland
- Postal code
- 02600
- Country
- Finland
Email patterns
See email patterns for Herantis Pharma Plc.
Address formats, how often each is used and the mail provider.
Start for freeTrade fairs
FAQ
What is the company name?
herantis.com is the website of Herantis Pharma Plc.
What is the industry of the company?
Herantis Pharma Plc. (herantis.com) is in the Biotechnology Research industry.
What products and services does the company offer?
Herantis Pharma Plc. (herantis.com) lists these specialties: Parkinson's disease, Neurodegenerative diseases, Biologics, biotech, and drug development.
When was the company founded?
Herantis Pharma Plc. (herantis.com) was founded in 2008.
How many employees does the company have?
Herantis Pharma Plc. (herantis.com) has 11-50 employees.
What is the company type?
The company type of Herantis Pharma Plc. (herantis.com) is Public Company.
Where is the company headquartered?
Herantis Pharma Plc. (herantis.com) is headquartered in Espoo, Southern Finland.
What is the address of the company?
The address of Herantis Pharma Plc. (herantis.com) is Bertel Jungin aukio 1, Espoo, Southern Finland, 02600, Finland.
What are the social media accounts of the company?
The social media account of Herantis Pharma Plc. (herantis.com) is LinkedIn.
Social media